Sarepta Therapeutics (SRPT) R&D/CAPEX US GAAP (year values) |
|||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
R&D/CAPEX, % | 894.4% | 878.7% | 2 004% | 2 845% | 1 005% | 748.9% | |||
Changes by years, y/y, % | +270pp | -16pp | +1 125pp | +842pp | -1 841pp | +10.0% |
Sarepta Therapeutics. R&D/CAPEX, %
Sarepta Therapeutics. R&D/CAPEX, changes, pp
Sarepta Therapeutics (SRPT) R&D/CAPEX US GAAP (quarter values) |
||||||||
2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
R&D/CAPEX, % | 2 590% | 1 351% | 474.9% | 1 027% | 599.0% | 748.9% | ||
Changes by years, y/y, % | -909pp | -1 429pp | -2 158pp | -1 658pp | -1 991pp | |||
Changes by quarters, q/q, % | -94pp | -1 240pp | -876pp | +552pp | -428pp |